If you have received a positive COVID screening result, you may be eligible for this study.

This study is being conducted by a group of doctors at the University of Toronto hospitals. The study is being done to see whether or not people who have been exposed to COVID-19 have genetic differences that might affect the response to infection and severity of the disease. The study will also look at the antibody response over time to understand whether a person is immune to the virus. This information helps to understand the risk of being reinfected by the virus at a later time. The study will also look at whether there is a relationship between genetic findings and the ability to produce or maintain antibodies over time.

As part of this study, your DNA will be sequenced and you will have the opportunity to receive this information as well as your antibody results and viral strain, if desired. We will look at antibodies in your blood at several time points to see if there are correlations between genetic findings and the severity of disease or risk of developing disease in the future. Your active participation in this study will last one year including sample and data collection at 1 month, 6 months, and 12 months’ time points.

If you are interested in finding out more, please contact the study team below.

Site PI
Dr. Marc Dagher

GENCOV Study Team (416) 586-4800 x 5738
If you leave a message by email or phone, please provide a phone number for us to call you back on and let us know if we can leave a message. You will be called back within 48 hours.